Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 97518)

Published in Infect Immun on May 01, 2000

Authors

B Samten1, E K Thomas, J Gong, P F Barnes

Author Affiliations

1: Center for Pulmonary and Infectious Disease Control, University of Texas Health Center, Tyler, Texas 75710, USA.

Articles citing this

Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect Immun (2001) 1.80

Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin Exp Immunol (2009) 1.42

Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway. Int J Exp Pathol (2002) 1.07

IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin Exp Immunol (2004) 1.07

Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis. Clin Vaccine Immunol (2008) 1.02

Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia. Clin Vaccine Immunol (2008) 1.01

Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect Immun (2001) 0.97

CD40 is required for the optimal induction of protective immunity to Mycobacterium avium. Immunology (2004) 0.91

Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!! PLoS Pathog (2012) 0.91

Trehalose 6,6'-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages. Microbes Infect (2008) 0.90

Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa. Immunogenetics (2003) 0.84

IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis. Autophagy (2014) 0.83

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults. PLoS One (2015) 0.81

Clinical disease upregulates expression of CD40 and CD40 ligand on peripheral blood mononuclear cells from cattle naturally infected with Mycobacterium avium subsp. paratuberculosis. Clin Vaccine Immunol (2013) 0.76

Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression. PLoS Negl Trop Dis (2017) 0.75

Articles cited by this

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A (1996) 3.07

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med (1993) 3.04

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol (1993) 2.53

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med (1996) 2.30

CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science (1996) 2.21

Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol (1995) 2.21

Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci U S A (1996) 2.15

CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity (1996) 2.11

Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity (1996) 2.05

Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98

CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today (1993) 1.91

CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol (1994) 1.87

The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today (1996) 1.84

Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun (1996) 1.77

Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74

Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun (1994) 1.73

Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J Immunol (1996) 1.64

TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol (1998) 1.59

CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol (1998) 1.33

CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol (1998) 1.32

CD40 ligand/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J Immunol (1998) 1.20

CD40 ligand is a T cell growth factor. Eur J Immunol (1993) 1.19

Biological function and distribution of human interleukin-12 receptor beta chain. Eur J Immunol (1996) 1.17

Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J Immunol (1997) 1.12

CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J Exp Med (1998) 1.12

Role of CD40 ligand in Mycobacterium avium infection. Infect Immun (1999) 1.11

CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol (1999) 1.09

CD40 ligand is expressed and functional on activated neonatal T cells. J Immunol (1996) 1.04

Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect Immun (1997) 1.01

Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol (1999) 0.98

Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells. Cancer Res (1998) 0.98

B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions. J Immunol (1997) 0.97

The role of B cells in in vitro induction of IFN-gamma-producing CD4+ T cells specific to Listeria monocytogens: positive and IL-10-mediated negative regulation. Cell Immunol (1994) 0.80

Articles by these authors

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax (2008) 4.79

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res (1993) 4.11

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis (1993) 4.01

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1999) 3.45

Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci (2000) 2.55

T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51

Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol (1998) 2.49

Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med (1990) 2.35

Phylogenetic analysis of rumen bacteria by comparative sequence analysis of cloned 16S rRNA genes. Anaerobe (1998) 2.31

Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29

Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol (1998) 2.29

Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol (1994) 2.06

Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98

The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res (1993) 1.88

Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85

Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res (2001) 1.78

Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med (1997) 1.76

Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74

Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis (1997) 1.70

IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65

Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia (2011) 1.63

Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J Gastroenterol (2001) 1.62

Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res (1999) 1.60

Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun (1998) 1.58

Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med (2001) 1.53

Evaluation of method for secondary DNA typing of Mycobacterium tuberculosis with pTBN12 in epidemiologic study of tuberculosis. J Clin Microbiol (1996) 1.52

Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51

Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia (1993) 1.50

The role of white cells in the transmission of Yersinia enterocolitica in blood components. Transfusion (1992) 1.48

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci U S A (1991) 1.47

Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry (1994) 1.45

Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med (1996) 1.43

Undiagnosed tuberculosis in patients with human immunodeficiency virus infection. Chest (1990) 1.41

Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene (2007) 1.40

Rapid diagnostic tests for tuberculosis: progress but no gold standard. Am J Respir Crit Care Med (1997) 1.40

Cytometry of cyclin proteins. Cytometry (1996) 1.40

Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia (2009) 1.37

Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem (1997) 1.36

CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis (1997) 1.32

Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression. Eur J Immunol (1999) 1.31

Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry (1987) 1.31

Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene (2007) 1.30

Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30

Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun (1998) 1.29

CD30 in normal and neoplastic cells. Clin Immunol (1999) 1.29

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine (1999) 1.27

A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood (2000) 1.26

The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses. J Immunol (2000) 1.23

Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis (2000) 1.21

Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. J Appl Microbiol (2006) 1.19

IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol (2000) 1.18

IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. J Leukoc Biol (2001) 1.18

DNA strand breaks occurring during apoptosis - their early insitu detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol (1992) 1.15

Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis (2001) 1.15

Hazard of smoking initiation by age among adolescents in Wuhan, China. Prev Med (2001) 1.15

Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med (1989) 1.15

Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res (2001) 1.14

Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mech Ageing Dev (2000) 1.14

Rapid and sensitive detection of Singapore grouper iridovirus by loop-mediated isothermal amplification. J Appl Microbiol (2008) 1.13

Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas. J Clin Microbiol (1999) 1.13

Structure, function and regulation of p63 and p73. Cell Death Differ (1999) 1.12

The T cell receptors of human gamma delta T cells reactive to Mycobacterium tuberculosis are encoded by specific V genes but diverse V-J junctions. J Immunol (1991) 1.11

Effects of spectral smearing on phoneme and word recognition. J Acoust Soc Am (1996) 1.10

Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br J Haematol (1997) 1.10

Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur J Immunol (2001) 1.10

Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis (2000) 1.10

Evidence for a superantigen in human tuberculosis. Immunity (1994) 1.10

Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell Immunol (1999) 1.08

Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations. Cancer Res (2001) 1.08

Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08

Antimycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. Chest (1990) 1.07

Group-specific 16S rRNA hybridization probes for determinative and community structure studies of Butyrivibrio fibrisolvens in the rumen. Appl Environ Microbiol (1997) 1.07

Pleuritis as a manifestation of reactivation tuberculosis. Am J Med (1990) 1.06

Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Cancer Res (1999) 1.06

5-Aminolevulinate synthase and the first step of heme biosynthesis. J Bioenerg Biomembr (1995) 1.06

Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study. Int J Clin Pract (2009) 1.05

16S rDNA analysis of Butyrivibrio fibrisolvens: phylogenetic position and relation to butyrate-producing anaerobic bacteria from the rumen of white-tailed deer. Lett Appl Microbiol (1996) 1.05

Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis (1996) 1.05

Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J Immunol (2000) 1.04

IL-15 stimulates the expansion of AIDS virus-specific CTL. J Immunol (1996) 1.04

Control of type II transforming growth factor-beta receptor expression by integrin ligation. J Biol Chem (1999) 1.04

LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene (2011) 1.03

Further characterization of Raccoonpox virus. Arch Virol (1975) 1.03

Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Brain Res Rev (1998) 1.02

Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang (1993) 1.02